France Breast Cancer Diagnostics And Therapeutics Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2025
France breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.1% during the forecast period. Increasing the incidence of breast cancer coupled with a growing awareness program towrds breast cancer diagnosis and treatment are the major factors that contributing to the growth of the market. According to the WHO, about 56,162 new breast cancer cases and 13,353 mortalities estimated in 2018. Institute curie is a key centre for the treatment of breast cancer in the country. The institute participating in more than 20 clinical trials for breast cancer on a variety of topics. The breast cancer screening program in France offers screening to women between 50 and 74 years of age which is covered by public health insurance.
To Request a Sample of our Report on France
Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/france-breast-cancer-diagnostics-therapeutics-market
France breast cancer diagnosis and
therapeutics market are segmented on the basis of cancer type, diagnostics, and
therapeutics. In cancer type segment market is further classified into ductal
carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative
breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics
technology, the segment market is further classified into mammography, biopsy,
position emission tomography/computed tomography, ultrasound, and others. The
therapeutics technology segment market is further segregated into chemotherapy,
hormone therapy, targeted therapy, and others.
(Get 15% Discount on Buying this Report)
A
full Report of France Breast Cancer Diagnostics And Therapeutics Market is
Available @ https://www.omrglobal.com/industry-reports/france-breast-cancer-diagnostics-therapeutics-market
France Breast Cancer
Diagnostics And Therapeutics Market Segmentation
By Cancer Type
·
Ductal Carcinoma In-Situ (DCIS)
·
Invasive Ductal Carcinoma (IDC)
·
Triple Negative Breast Cancer (TNBC)
·
Inflammatory Breast Cancer
·
Others (Invasive lobular carcinoma)
By Diagnostics
·
Mammography
·
Biopsy
·
PET/CET
·
Ultrasound
·
Others (MRI)
By Therapeutics
·
Chemotherapy
·
Hormone Therapy
·
Targeted Therapy
·
Others (Radiation Therapy, Surgery)
Company Profiles
·
Agendia NV
·
AstraZeneca PLC
·
Bayer AG
·
GlaxoSmithKline PLC
·
Mylan NV
·
Merck & Co., Inc.
·
Novartis International AG
·
F. Hoffmann-La Roche AG
·
Sanofi S.A.
·
Siemens Healthcare GmbH
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment